| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/15/1999 | EP0941245A1 Promoter for smooth muscle cell expression |
| 09/15/1999 | EP0941242A2 Secreted proteins and polynucleotides encoding them |
| 09/15/1999 | EP0941239A1 Vertebrate homologues of unc-53 protein of c. elegans |
| 09/15/1999 | EP0941125A1 Methods for regulating angiogenesis |
| 09/15/1999 | EP0941027A1 Msc-megakaryocyte precursor composition and method of isolating mscs associated with isolated megakaryocytes by isolating megakaryocytes |
| 09/15/1999 | EP0851874B1 Novel variants of green fluorescent protein, gfp |
| 09/15/1999 | EP0776335A4 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 09/15/1999 | EP0586657B1 Receptor for the glucagon-like-peptide-1 (glp-1) |
| 09/15/1999 | EP0575390B1 Maize cells capable of resisting herbicides of the aryloxy-phenoxy-alkane carboxylic acid type and method of producing herbicide-resistant maize cell lines |
| 09/15/1999 | CN1228814A Cassava vein mosaic virus promoters and uses thereof |
| 09/15/1999 | CN1228813A Gene conferring disease resistance in plants and uses thereof |
| 09/15/1999 | CN1228811A Modulators of BRCAI activity |
| 09/15/1999 | CN1228784A Nucleic acid encoding GAI gene of arabidopsis thaliana |
| 09/14/1999 | US5952547 Modified Bacillus thuringiensis genes with improved expression in plant cells, methods of production on and use |
| 09/14/1999 | US5952545 Nucleic acid molecules encoding cytochrome P450-type proteins involved in the brassinosteroid synthesis in plants |
| 09/14/1999 | US5952544 Fatty acid desaturase genes from plants |
| 09/14/1999 | US5952488 A nucleic acid molecule containing an androgen response element linked to a reporter gene; diagnosis and therapy for prostatic diseases and cancer |
| 09/14/1999 | US5952485 Procedures and materials for conferring disease resistance in plants |
| 09/14/1999 | US5952483 Human IκB-β |
| 09/14/1999 | US5952481 DNA encoding ubiquitin conjugating enzymes |
| 09/14/1999 | US5952472 Anti-fibroblast growth factor-8 monoclonal antibody |
| 09/14/1999 | US5952469 Murine UCP3 polypeptides |
| 09/14/1999 | US5952468 Isolated nucleic acid molecules which encode TAGE molecules, and uses thereof |
| 09/14/1999 | US5952311 Photosensitizing chemical means for killing tumor cells, wherein tumoricidal activity is activated by absorbing light or energy within a specific wavelength range, and energy donating chemical means for activating photosensitizer |
| 09/14/1999 | US5952301 A synergistic mixture of the peptide hormones, glucagon-like peptide-2 (glp-2) and insulin-like growth factor (igf-1,2) or growth hormone to promote the cell growth in the large and small intestines; nutritional, gastrointestinal disorders |
| 09/14/1999 | US5952229 Antisense oligonucleotide modulation of raf gene expression |
| 09/14/1999 | US5952227 Human embryonic lung fibroblast diploid cell strain suitable for the production of virus and process for the production of varicella zoster virus using same |
| 09/14/1999 | US5952225 A packaging cell containing a polynucleotide which codes a portion of a selected retrovirus having at least the envelope protein; for producing vectors resistant to complement inactivation by serum; gene therapy |
| 09/14/1999 | US5952224 Culturing cells with a concentration of an adhesion ligand (arginine-glycine-aspartic sequence), binding less than all adhesion surface receptors on the cells selecting cells able to grow, reculturing in higher concentrations of ligand |
| 09/14/1999 | US5952222 Functional enucleation of bovine oocytes |
| 09/14/1999 | US5952221 A virion having a drug-sensitivity gene and a second gene capable of providing ancillary effects to solid tumor cells; gene therapy and antitumor agents |
| 09/14/1999 | US5952215 Enzyme composition for tissue dissociation |
| 09/14/1999 | US5952214 Human growth-related CDC10 homolog |
| 09/14/1999 | US5952199 A protein that contains an immunoglobulin-like domain; antiproliferative/antitumor agents, treatment of rheumatoid arthritis, psoriasis, diabeties, glaucoma, muscular disorders and immune rejection of eye transplants |
| 09/14/1999 | US5952198 Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition |
| 09/14/1999 | US5952187 Antiepileptic agent analog derivatized at the sulfamate moiety or the 9-carbon methyl group to add label for use in immunoassays or to add carrier for use as immunogen; for monitoring serum or plasma levels of drug |
| 09/14/1999 | US5952181 Hybridizing polynucleotide sequence to complementary polynucleotide forming a complex, detecting complex formation; anticarcinogenic agent, treatment of psychological disorders, alzheimer's disease |
| 09/14/1999 | US5952175 DNA encoding a human progesterone receptor complex p23-like protein |
| 09/14/1999 | US5952169 Identification of DNA-damaging substances by means of cell lines capable of overexpressing poly (ADP-ribose)--polymerase |
| 09/14/1999 | US5952002 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor |
| 09/14/1999 | US5951976 Vaccinating a mammal by administering a composition comprising an opsonin-enhanced cell comprising said selected antigen with the provision the opsonin does not bind to a receptor for a fragment of c33 |
| 09/14/1999 | CA2159449C Oesteoblast growth stimulating composition containing pdgf and vitamin d |
| 09/14/1999 | CA2132208C Method of eliminating inhibitory/instability regions of mrna |
| 09/14/1999 | CA2079229C Ubiquitin-specific protease |
| 09/14/1999 | CA1340739C Process for transforming plant protoplasts |
| 09/14/1999 | CA1340736C Method for genetically modifying a plant cell for plant gene expression |
| 09/14/1999 | CA1340732C Sv40 expression vector containing hbxag as an expression marker |
| 09/11/1999 | CA2253946A1 Method for regulating cell death |
| 09/10/1999 | WO1999045135A1 Novel fdrg protein and nucleic acid molecules and uses therefor |
| 09/10/1999 | WO1999045129A1 Method for the induction of pathogen resistance in plants |
| 09/10/1999 | WO1999045127A2 Enhanced prodrug activation |
| 09/10/1999 | WO1999045126A2 Enhanced prodrug activation |
| 09/10/1999 | WO1999045122A1 Modification of fatty acid metabolism in plants |
| 09/10/1999 | WO1999045115A1 Human synapse related glycoproteins (hsrp) |
| 09/10/1999 | WO1999045111A1 Lectomedin materials and methods |
| 09/10/1999 | WO1999045108A2 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines |
| 09/10/1999 | WO1999045105A2 Highly crystalline urokinase |
| 09/10/1999 | WO1999045103A2 Human spinal cord cell lines and methods of use therefor |
| 09/10/1999 | WO1999045102A1 Method for activating natural killer (nk) cells |
| 09/10/1999 | WO1999045097A2 Methods and apparatus for the conditioning of ligament replacement tissue |
| 09/10/1999 | WO1999045096A1 Culture dish |
| 09/10/1999 | WO1999045019A1 Isolated nucleic acid molecules which encode tage molecules, and uses thereof |
| 09/10/1999 | WO1999044629A2 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 09/10/1999 | WO1999044487A2 Genetic engineering of prosthetic bypass grafts |
| 09/10/1999 | WO1999035263A3 Il-17rh dna and polypeptides |
| 09/10/1999 | WO1999033967A3 Novel nucleic acid and polypeptide with homology to the tnf-receptors |
| 09/10/1999 | WO1999032644A3 Prostate cancer gene |
| 09/10/1999 | WO1999032514A3 Sag: sensitive to apoptosis gene |
| 09/10/1999 | WO1999031236A3 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 09/10/1999 | WO1999027977A3 Bone matrix, the utilization thereof, therapeutic preparation and kit |
| 09/10/1999 | WO1999027958A9 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/10/1999 | WO1999025829A3 Cdk2 protein and cdk2 protein complexes |
| 09/10/1999 | WO1999025817A9 Tc1-based transposon vectors |
| 09/10/1999 | WO1999024472A8 Glycosylated antibodies and antibody fragments having reactive ketone groups |
| 09/10/1999 | WO1999020756A3 Human toll homologues |
| 09/10/1999 | WO1999020644A9 Secreted proteins and polynucleotides encoding them |
| 09/10/1999 | CA2322831A1 Methods and apparatus for the conditioning of ligament replacement tissue |
| 09/10/1999 | CA2322731A1 Lectomedin materials and methods |
| 09/10/1999 | CA2322712A1 Method for activating natural killer (nk) cells |
| 09/10/1999 | CA2322684A1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes |
| 09/10/1999 | CA2322664A1 Enhanced prodrug activation |
| 09/10/1999 | CA2322622A1 Highly crystalline urokinase |
| 09/10/1999 | CA2322425A1 Novel fdrg protein and nucleic acid molecules and uses therefor |
| 09/10/1999 | CA2322382A1 Method for the induction of pathogen resistance in plants |
| 09/10/1999 | CA2322381A1 Human synapse related glycoproteins (hsrp) |
| 09/10/1999 | CA2249661A1 Novel compounds |
| 09/10/1999 | CA2249041A1 Novel compounds |
| 09/09/1999 | DE19808734A1 New human cell line, useful for regulated expression of proteins, for studying liver-specific interaction of gene products |
| 09/09/1999 | DE19808192A1 Diisopropylfluorophosphatase sowie deren Verwendung und Herstellung Diisopropyl fluorophosphatase and their use and production |
| 09/08/1999 | EP0939832A1 Mitochondrial dna mutations that segregate with late onset diabetes mellitus |
| 09/08/1999 | EP0939827A1 Lentiviral vectors |
| 09/08/1999 | EP0939824A1 Reagents and methods useful for detecting diseases of the breast |
| 09/08/1999 | EP0939822A2 Use of mutated macrolide binding protein for the prevention of guhd |
| 09/08/1999 | EP0939820A1 Nucleic acid sequences that encode a cell growth regulatory protein and uses thereof |
| 09/08/1999 | EP0939819A1 Mini-e1a genes and gene products |
| 09/08/1999 | EP0939818A1 Recombinant toxin fragments |
| 09/08/1999 | EP0939817A2 High-affinity interleukin-4 muteins |
| 09/08/1999 | EP0939816A1 Circularly permuted erythropoietin receptor agonists |
| 09/08/1999 | EP0939815A1 IDENTIFICATION OF Bap-1, A PROTEIN THAT BINDS TO INTEGRIN AND IS INVOLVED IN INTEGRIN-MEDIATED SIGNAL TRANSDUCTION |
| 09/08/1999 | EP0939812A2 Novel human macrophage antigen |